HOME › DRUGS › BREXUCABTAGENE AUTOLEUCEL
ACTIVE SUBSTANCE / INN

BREXUCABTAGENE AUTOLEUCEL

Brand name(s): Tecartus
EMA LISTED
AUTHORISED
Lymphoma, Mantle-Cell
ACTIVE SUBSTANCE
Brexucabtagene Autoleucel
REGULATORS
EMA
SPONSORS / MAH
Kite Pharma EU B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TecartusKite Pharma EU B.V.Authorised14/12/2020Lymphoma, Mantle-Cell

FULL INTELLIGENCE ON BREXUCABTAGENE AUTOLEUCEL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →